Last updated: May 21, 2024
Sponsor: IRCCS Eugenio Medea
Overall Status: Active - Recruiting
Phase
N/A
Condition
Williams Syndrome
Asperger's Disorder
Treatment
Magnetic resonance imaging
Clinical Study ID
NCT06432023
1022
Ages 2-75 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- patients with white matter lesions and/or enlarged perivascular spaces
Exclusion
Exclusion Criteria:
have contraindications to the use of contrast medium;
are clinically unstable patients and prolonged sedation is inappropriate
have tumors
contraindications to perform MR.
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: Magnetic resonance imaging
Phase:
Study Start date:
October 01, 2023
Estimated Completion Date:
January 31, 2026
Study Description
Connect with a study center
Scientific Institute IRCCS E. Medea
Bosisio Parini, Lecco 23842
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.